Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipogems MFat in Knee Osteoarthritis (ARISE2)
NCT06121882Phase 3Active, not recruiting
- Sponsor
- Lipogems
- Start
- Mar 2024
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial (2 arms), sponsored by Lipogems. Primary endpoints: Western Ontario and McMaster Universities Osteoarthritis Index Pain (WOMAC-A) Visual Analog Scale (VAS) Score at 12 months and Western Ontario and McMaster Universities Osteoarthritis Index Function (WOMAC-C) Subscale Score at 12 months. Started Mar 2024; status: active, not recruiting.
Beyond the preview
Go deeper on NCT06121882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06121882.